|
|
|
|
Document Preview Common Stock Purchase Warrant |
||||
|
|
||||
|
Click "Add to Cart" button to purchase document. |
||||
|
|
||||
|
Title: |
Common Stock Purchase Warrant |
|||
|
Entities: |
Endovasc, Inc.; Endovasc Ltd., Inc.; Laurus Master Fund, Ltd. |
|||
|
Date: |
2001 |
|||
|
Size: |
Preview shows 5KB of 32KB total |
|||
|
Price: |
$43 |
|||
|
ID: |
#301869 |
|||
|
|
||||
|
||||
|
|
||||
|
Start of Preview |
||||
THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT
AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD,
OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SAID ACT OR AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO ENDOVASC LTD., INC. THAT SUCH REGISTRATION IS
NOT REQUIRED.
Right to Purchase 100,000 Shares of Common Stock of Endovasc Ltd.,
Inc. (subject to adjustment as provided herein)
COMMON STOCK PURCHASE WARRANT
No. 2001-2 Issue Date: August 17, 2001
ENDOVASC LTD., INC., a corporation organized under the laws of the
State of Nevada (the "Company"), hereby certifies that, for value received,
LAURUS MASTER FUND, LTD., or assigns, is entitled, subject to the terms set
forth below, to purchase from the Company from and after the Issue Date of this
Warrant and at any time or from time to time before 5:00 p.m., New York time,
through five (5) years after such date (the "Expiration Date"), up to 100,000
fully paid and nonassessable shares of Common Stock (as hereinafter defined),
$.001 par value per share, of the Company, at a purchase price of the lesser of
(i) $0.0612 per share or (ii) 120% of the average of the three lowest closing
prices of the Common Stock as reported by Bloomberg Financial for the Principal
Market (as defined in the Subscription Agreement hereinafter referred to) for
the ten trading days immediately preceding the date of the exercise of this
Warrant (such purchase price per share as adjusted from time to time as herein
provided is referred to herein as the "Purchase Price"). The number and
character of such shares of Common Stock and the Purchase Price are subject to
adjustment as provided herein.
As used herein the following terms, unless the context otherwise
requires, have the following respective meanings:
(a) The term "Company" shall include Endovasc Ltd., Inc. and any
corporation which shall succeed or assume the obligations of Endovasc Ltd.,
Inc. hereunder.
(b) The term "Common Stock" includes (a) the Company's Common Stock,
$.001 par value per share, as authorized on the date of the Subscription
Agreement referred to in Section 9 hereof, (b) any other capital stock of any
class or classes (however designated) of the Company, authorized on or after
such date, the holders of which shall have the right, without limitation as to
amount, either to all or to a share of the balance of current dividends and
liquidating dividends after the payment of dividends and distributions on any
shares entitled to preference, and the holders of which shall ordinarily, in the
absence of contingencies, be entitled to vote for the election of a majority of
directors of the Company (even if the right so to vote has been suspended by the
happening of such a contingency) and (c) any other securities into which or for
which any of the securities described in (a) or (b) may be converted or
exchanged pursuant to a plan of recapitalization, reorganization, merger, sale
of assets or otherwise.
(c) The term "Other Securities" refers to any stock (other than Common
Stock) and other securities of the Company or any other person (corporate or
otherwise) which the holder of the Warrant at any time shall be entitled to
receive, or shall have received, on the exercise of the Warrant, in lieu of or
in addition to Common Stock, or which at any time shall be issuable or shall
have been issued in exchange for or in replacement of Common Stock or Other
Securities pursuant to Section 4 or otherwise.
1
{PAGE}
1. Exercise of Warrant.
-------------------
1.1. Number of Shares Issuable upon Exercise. From and after
the date hereof through and including the Expiration Date, the holder hereof
shall be entitled to receive, upon exercise of this Warrant in whole in
accordance with the terms of subsection 1.2 or upon exercise of this Warrant in
part in accordance with subsection 1.3, shares of Common Stock of the Company,
subject to adjustment pursuant to Section 4.
1.2. Full Exercise. This Warrant may be exercised in full by
the holder hereof by delivery of an original or fax copy of the form of
subscription attached as Exhibit A hereto (the "Subscription Form") duly
executed by such holder and surrender of the original Warrant within seven days
|
End of Preview |
Home Intelligence Services Subscriptions News About Us